4.7 Article

The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8α+ dendritic cells

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 207, 期 6, 页码 1283-1292

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20100223

关键词

-

资金

  1. Association pour la recherche sur le cancer
  2. CNRS
  3. Agence nationale de recherches sur le SIDA et les hepatites virales
  4. Institut National de la Sante et de la Recherche Medicale
  5. Ligue nationale contre le cancer
  6. Agence nationale de la recherche

向作者/读者索取更多资源

Human BDCA3(+) dendritic cells (DCs) were suggested to be homologous to mouse CD8 alpha(+) DCs. We demonstrate that human BDCA3(+) DCs are more efficient than their BDCA1(+) counterparts or plasmacytoid DCs (pDCs) in cross-presenting antigen and activating CD8(+) T cells, which is similar to mouse CD8 alpha(+) DCs as compared with CD11b(+) DCs or pDCs, although with more moderate differences between human DC subsets. Yet, no specific marker was known to be shared between homologous DC subsets across species. We found that XC chemokine receptor 1 (XCR1) is specifically expressed and active in mouse CD8 alpha(+), human BDCA3(+), and sheep CD26(+) DCs and is conserved across species. The mRNA encoding the XCR1 ligand chemokine (C motif) ligand 1 (XCL1) is selectively expressed in natural killer (NK) and CD8(+) T lymphocytes at steady-state and is enhanced upon activation. Moreover, the Xcl1 mRNA is selectively expressed at high levels in central memory compared with naive CD8(+) T lymphocytes. Finally, XCR1(-/-) mice have decreased early CD8(+) T cell responses to Listeria monocytogenes infection, which is associated with higher bacterial loads early in infection. Therefore, XCR1 constitutes the first conserved specific marker for cell subsets homologous to mouse CD8(+) DCs in higher vertebrates and promotes their ability to activate early CD8(+) T cell defenses against an intracellular pathogenic bacteria.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据